| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b2f4f4fcdd64cc67aeaa65ceac95a179
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e3b16a0166002c696a640b59355e0b5e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_81616652a47c6fc3e6b477a1a0eec72d |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-6081 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-385 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-385
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-08 |
| filingDate |
1993-11-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_831ed952f73342844d691d1fe24b3227
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e1ff73d139778500b2a9f217dc87c9fe
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_196f4bc4d384e93fab4f51cedc55726e |
| publicationDate |
1994-06-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-9412213-A1 |
| titleOfInvention |
Method of producing antibodies with conjugates of b-cell-antigen and denatured carrier |
| abstract |
Antibodies to haptens and other B cell antigens are provided in animals by a process wherein the B cell antigen is introduced into the animal in a form in which it is coupled to an immunogenic carrier molecule in the form of a protein antigen which normally induces both T cell and B cell immunity. The process is unique in that the immunogenic protein antigen is modified to an exclusive or predominant T cell antigen by a denaturating modification of the antigen, that the B cell antigen to which antibodies are to be provided is coupled to the modified T cell antigen, followed by immunization, optionally using an adjuvant as an immune stimulating means, preferably after preimmunization with T cell antigen in a form that may be different from the form used in the immunization proper with the B cell antigen. The produced antigens are particularly used in the production of vaccines for veterinary medicinal use. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0197842-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9228024-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8535664-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7923009-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9273117-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9308259-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9303091-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0238611-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8871203-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9303090-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8894995-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9308275-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9382332-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9561273-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9566332-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7815904-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8066992-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6663861-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8815245-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0238611-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9200081-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8637030-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8241625-B2 |
| priorityDate |
1992-11-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |